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Background: The suitability of the proximal landing zone remains one of the main limitations to thoracic endovascular
aortic repair (TEVAR). The advent of custom-made scalloped stent grafts widens the endovascular options for patients
with challenging anatomy. The objective of this study was to present our early and midterm results of custom-made
scalloped thoracic stent grafts.
Methods: Prospectively acquired data relating to patient demographics, procedure details, clinical outcome, and compli-
cations were analyzed. In addition, we analyzed preoperative and postoperative computed tomography scans to evaluate
aneurysm morphology, graft placement, side-vessel patency, and endoleaks.
Results: Twenty-one patients with a median age of 71 years (range, 35-81 years) underwent custom-made scalloped
TEVAR, eight of whom had a concomitant hybrid repair. Procedural success was achieved in all cases. Proximal seal was
achieved in all cases, with no type I endoleaks. There were no cases of retrograde dissection and no conversions to open
repair. The median follow-up period was 36 weeks (range, 3-183 weeks). Two patients died in the hospital. Three patients
suffered a stroke. Three patients had a type II endoleak, one of whom had signiﬁcant sac enlargement requiring
reintervention. One patient had a type III endoleak requiring reintervention. There were no cases of graft migration.
Conclusions: Our midterm results show that custom-made scalloped TEVAR is an acceptable treatment of thoracic aortic
aneurysms with a short proximal landing zone. Longer term outcome data are required to establish wider use of scalloped
thoracic endografts. (J Vasc Surg 2014;60:1499-506.)Thoracic endovascular aortic aneurysm repair (TEVAR)
is an established treatment of thoracic aortic disease in
both the acute and elective setting.1 TEVAR is associated
with lower early mortality and morbidity compared with
open surgical repair, making it an attractive therapeutic
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://dx.doi.org/10.1016/j.jvs.2014.08.062The feasibility of TEVAR is determined by several
anatomic factors, including landing zones. Adequate prox-
imal and distal landing zones of healthy aorta are manda-
tory for endovascular treatment to prevent stent graft
migration and to reduce the risk of endoleak.
Scalloped endografts are one strategy in overcoming
the problem of a short proximal landing zone. These are
custom-made covered stent grafts with a scallop designed
to accommodate the origin of a supra-aortic vessel, which
would otherwise be covered or require revascularization.
Most often, the proximal scallop is to the left subclavian
artery (LSCA), but it has also been successfully used to
accommodate common carotid and innominate vessels
either with extra-anatomic bypass for covered vessels or
by use of fenestrated grafts as an alternative.5-7 Distal celiac
and superior mesenteric artery scallops have also been
described.8-10
In this paper, we discuss our early and midterm out-
comes using TEVAR with a proximal scallop or fenestra-
tion in treating thoracic aortic disease with inadequate
proximal landing zones.
METHODS
All cases were discussed at our specialist vascular multi-
disciplinary team meeting before their surgery. Our proto-
col was to select TEVAR with a custom-made scalloped
stent graft in patients with a thoracic aortic aneurysm
with a proximal landing zone of <20 mm (as measured1499
Fig 1. A and B, Three-dimensional reconstructions from computed tomography angiography of the aorta before and
after (18 months) scalloped thoracic endovascular aortic repair (TEVAR). C and D, Images from digital subtraction
angiography of the aortic arch before and after TEVAR with a scalloped endograft demonstrating isolation of the
thoracic aortic aneurysm and patency of the left subclavian artery (LSCA).
JOURNAL OF VASCULAR SURGERY
1500 Alsaﬁ et al December 2014from the distal wall of the LSCA) and in cases in which
there was signiﬁcant angulation of the arch necessitating
a longer length of landing zone for adequate graft apposi-
tion and seal.
Patients with more extensive aortic arch disease under-
went scalloped TEVAR with arch vessel extra-anatomic
revascularization or, more recently, endograft placement
with a fenestration and a scallop.
All patients were entered into our postoperative surveil-
lance program, undergoing follow-up computed tomogra-
phy angiography at 3 months, 6 months, 1 year, and
biannually thereafter in the absence of symptoms and com-
plications. Fig 1 illustrates preoperative and postoperative
imaging for a typical patient.Prospectively acquired data relating to patient demo-
graphics, procedure details, clinical outcomes, and compli-
cations were analyzed. In addition, two vascular
interventional radiologists (M.H. and A.A.) independently
analyzed preoperative and postoperative scans to evaluate
aneurysm morphology (aneurysm size, morphologic
features, type and length of the proximal landing zones),
graft placement, migration, supra-aortic vessel patency,
and endoleaks.
Ethics approval was not required for this retrospective
study.11
Stent grafts. We used the CE-marked custom-made
Bolton Relay scalloped stent grafts (Relay NBS; Bolton
Medical, Barcelona, Spain) (Fig 2). These are self-expanding
Fig 2. A, Image of a Bolton Medical scalloped endograft. B, Schematic showing a scalloped stent graft with the
radiopaque markers used during positioning. With permission from Bolton Medical.
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with a curved nitinol wire along the length of the graft to
provide longitudinal support. In addition to the radiopaque
end markers, there are four more markers delineating the
position of the scallop. The delivery system consists of a
series of coaxially arranged sheaths and catheters: a “stiff”
hydrophilic introducer to deliver the device through the
iliac arteries and a ﬂexible sheath containing the stent graft
that allows the device to track through the tortuous course
of the thoracic aorta. In cases in which proximal readjust-
ment is required, the delivery system allows distal tip
recapture.12
Stent grafts were manufactured according to preopera-
tive computed tomography angiography measurements,
with a custom-made scallop created in situ. Turnaround
time from order to delivery was 4 to 6 weeks.
Graft sizing. Stent grafts were sized using the Philips
Extended Brilliance Workspace (Philips Medical Systems,Best, The Netherlands). The true landing zone as well
as the working landing zone was assessed. The working
landing zone incorporated the vessel around which the
scallop ﬁts. A minimum of 20-mm working landing
zone was required to obtain an adequate proximal seal
with scalloped stent grafts. The diameter of the aorta at
the native landing zone was assessed with images cor-
rected to the centerline followed by 10% to 20% stent
oversizing. All stent measurements and intraoperative
C-arm positioning were determined preoperatively by
one operator (M.H.) and agreed to by a second operator
as well as the manufacturer.
Technique. Informed written consent was obtained
from all patients. Except for patient 8, who underwent
TEVAR under sedation and regional anesthesia, all other
patients had surgery under general anesthesia. In cases of
hybrid repair, revascularization procedures preceded endo-
vascular repair. Patients were nursed in a dedicated vascular
Table I. Demographics and comorbidities of patients
(N ¼ 21)
Age (range), years 71 (35-81)
Sex
Male 9
Female 12
Hypertension 14 (67)
Smoking history 12 (57)
Diabetes mellitus 1 (5)
COPD 5 (24)
Renal insufﬁciency 4 (19)
CAD 4 (19)
Previous MI 1 (5)
Previous cardiac surgery/intervention 9 (43)
Initial presentation with acute aortic syndrome 5 (24)
Previous infrarenal aortic surgery 2 (10)
Previous open thoracic aortic surgery 3 (14)
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary
disease; MI, myocardial infarction.
Data are presented as number (%) unless otherwise indicated.
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TEVAR were discharged the following day in the
absence of postoperative complications.
The procedure steps have been previously described by
Kashef et al.7 All patients had a femoral cutdown as means
of access for thoracic stent insertion. A pigtail catheter was
introduced into the aortic arch for intraprocedural angiog-
raphy through a left brachial artery puncture.
The stent grafts were introduced through a 60-cm
sheath in the common femoral artery; 5000 IU of unfrac-
tionated heparin was administered at this stage. The deliv-
ery system was introduced into the mid-descending aorta,
followed by further advancement of the secondary sheath
into the aortic arch. The LSCA was identiﬁed by means
of arch angiography through the pigtail catheter. Two an-
giograms at perpendicular angles were obtained to aid posi-
tioning of the scallop. An angiogram “opening” the aortic
arch was used to align the distal marker of the scallop just
distal to the LSCA. A perpendicular angiogram was also
obtained to aid clock face alignment. The stent graft was
adjusted to ensure that the scallop’s side markers were posi-
tioned on either side of the LSCA.
In cases of misalignment, the graft was pulled back to
the descending aorta, reoriented, and then readvanced.
Systolic blood pressure was lowered gradually to 70 mm
Hg just before stent graft deployment to avoid the “wind-
sock” effect. The grafts were deployed in accordance with
the manufacturer’s instructions.
A completion angiogram was obtained in all cases.RESULTS
Twenty-one patients with a median age of 71 years
(range, 35-81 years) underwent scalloped TEVAR. Thir-
teen of these had a stand-alone scalloped TEVAR and eight
had scalloped TEVAR with extra-anatomic revasculariza-
tion. Of those who underwent extra-anatomic bypass,
ﬁve underwent an arch hybrid repair and three had visceral
revascularization.
Patient demographics are described in Table I. Proce-
dure details are listed in Table II.
The median hospital stay was 8 days (2-157 days). Pa-
tients 2, 3, and 4 were admitted to the intensive care unit
for 7, 21, and 79 days, respectively. The median follow-up
period was 36 (3-183) weeks. Endoleaks and complications
are shown in Table III.
Seal and endoleaks. Proximal seal was achieved in all
cases with no type I endoleaks to date.
A type II endoleak was demonstrated at 52 weeks in
patient 4, which persisted at 128 weeks and resulted in
asymptomatic enlargement of the aneurysm sac (from
45 mm to 73 mm). This patient had an arch hybrid repair
with innominate reimplantation, carotid-carotid bypass,
and left common carotid artery (LCCA)eLSCA bypass.
The scallop was to the neoinnominate artery with resultant
type II endoleak from the covered LSCA. This was success-
fully treated by endovascular embolization of the LSCAwith
a combination of an Amplatzer vascular plug and coils.Patient 7 had a type II endoleak frommultiple intercostal
arteries detected on completion computed tomography
angiography, with no signiﬁcant sac enlargement during
the follow-up period of 16 weeks and no reintervention.
Patient 18 developed a type II endoleak 1 year after
TEVAR with no signiﬁcant sac enlargement.
Patient 10 had a type III endoleak from LSCA fenes-
tration around his covered branch stent, which persisted af-
ter balloon molding. There was no signiﬁcant sac
enlargement recorded at 23-week follow-up. The fenestra-
tion diameter in this patient was particularly wide (16 mm),
making a bridging stent seal difﬁcult. This was avoided
with patient 18, in whom a 10-mm fenestration was used
with no endoleak.
Stroke. Patients 3, 4, and 5 suffered a stroke. They had
an arch hybrid, a visceral hybrid, and a stand-alone scal-
loped TEVAR, respectively. Patient 3 suffered postoperative
right-sided weakness secondary to multiple left middle
cerebral artery territory embolic infarcts. Patient 4 had mul-
tiple bilateral embolic infarcts resulting in bilateral leg weak-
ness. Patient 5 suffered acute blindness secondary to a right
posterior cerebral artery territory infarct on a background of
a previous contralateral posterior cerebral artery stroke.
Mortality. The 30-day mortality was 5%. Patients 3
and 7 died in the hospital after 3 and 22 weeks, respec-
tively, both from multiorgan failure and hospital-acquired
pneumonia in the intensive care unit. Both had under-
gone TEVAR with a concomitant visceral hybrid repair for
extent II thoracoabdominal aortic aneurysm. Three other
patients died during the follow-up period: patient 5 in the
community from unknown causes at 22 weeks; patient 10
from a pontine hemorrhage at 31 weeks; and patient 1, who
died in the hospital after open surgical repair of an abdominal
aortic aneurysm 120weeks after his uncomplicated TEVAR.
Other complications. Patient 7 suffered paraplegia af-
ter visceral hybrid repair. This was likely due to extensive
coverage of the aorta and occurred despite insertion of a
spinal drain.
Table II. Original aortic disease, original size, and procedure undergone
Patient Original disease
Original
size, cm Symptomatic?
Landing
zone type Scallop to? Hybrid?
1 Descending TAA 7.4 No 3 LSCA N/A
2 Type II TAAA 6.2 No 3 LSCA Hybrid visceral revascularization
3 Type II TAAA 6.6 No 3 LSCA Hybrid visceral revascularization
4 Marfan syndrome, type A
dissection with aneurysmal
dilation of the
thoracoabdominal aorta
4.5 Yes 3 Neoinnominate Arch hybrid repair with
innominate reimplantation,
carotid-carotid and LCCA-
LSCA bypass
5 Contained rupture of a thoracic
aortic aneurysm
7 Yes 2 LSCA N/A
6 Saccular aneurysm just distal to
LSCA
4 No 3 LSCA N/A
7 Type II TAAA 7.8 No 3 LSCA Hybrid visceral revascularization
8 Saccular aneurysm just distal to
LSCA
5.6 No 3 LSCA N/A
9 Post-traumatic aortic arch
pseudoaneurysm
4.5 No 2 LSCA N/A
10 Degenerative arch aneurysm
extending from the ascending
aorta into the mid-descending
thoracic aorta
6.3 No 0 LSCA fenestration Arch hybrid repair with LCCA-
innominate grafts from the
proximal ascending aorta
11 Saccular aneurysm of the aortic
arch at the level of the LSCA
3.6 No 2 LCCA Arch hybrid with LSCA-LCCA
bypass
12 Post-traumatic pseudoaneurysm
distal to LSCA
3.7 Yes 3 LSCA N/A
13 Pseudoaneurysm after
coarctation repair
3.9 No 2 LSCA N/A
14 Pseudoaneurysm after
coarctation repair
3.2 No 3 LSCA N/A
15 Penetrating ulcer with a
pseudoaneurysm on the
underside of the aortic arch
3.5 Yes 3 LSCA N/A
16 Saccular aneurysm on the
underside of the aortic arch at
level of LSCA
6.4 Yes 2 LSCA N/A
17 Post-traumatic saccular thoracic
aortic aneurysm distal to
LSCA
7 No 3 LSCA N/A
18 Focal partially thrombosed
aortic arch ulcer
5.3 No 2 LCCA scallop and
LSCA fenestration
with a covered
stent
N/A
19 Partially thrombosed arch
aneurysm; previous
descending thoracic aortic
TEVAR
6.9 No 2 LCCA Arch hybrid with LCCA-LCSA
bypass
20 Fusiform aortic arch aneurysm 6.6 No 2 LCCA Arch hybrid with LCCA-LSCA
bypass and Amplatzer
occlusion of the LSCA origin
21 Post-coarctation repair
Pseudoaneurysm at the lateral
aspect of the aortic arch at the
level of the LSCA
3.5 No 3 LSCA N/A
LCCA, Left common carotid artery; LSCA, left subclavian artery; N/A, not applicable; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal aortic
aneurysm; TEVAR, thoracic endovascular aneurysm repair.
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from a small left subclavian hematoma at the site of his
LSCA-LCCA bypass.
Patient 21 had inadvertent partial coverage of the
LSCA, requiring deployment of a noncovered stent. The
vessel remained patent with no signiﬁcant effect on ﬂow
and no pressure gradient across the stent. No endoleak
was demonstrated on completion imaging.The median hospital stay for the ﬁrst 10 patients was
14 days compared with 3.5 days for the latter 11 patients.
All in-hospital deaths, strokes, paraplegia, cardiovascular
complications, and endoleaks occurred in the ﬁrst half of
the study.
Results in patients undergoing TEVAR without
extra-anatomic bypass. Thirteen patients with a median
age of 71 years (35-80 years) had a stand-alone scalloped
Table III. Summary of complications
Complication N ¼ 21
Early (within 30 days)
In-hospital death 1 (5)
Major stroke 3 (14)
Transient ischemic attack 0 (0)
Permanent paraplegia 1 (5)
Retrograde aortic dissection 0 (0)
Early endoleaks (within 30 days)
Type Ia 0 (0)
Type Ib 0 (0)
Type II 1 (5)
Type III 1 (0)
Endoleak requiring reintervention 0 (0)
Late (after 30 days)
Follow-up in weeks, median (range) 36 (3-183)
Aorta-related death 0 (0)
All-cause death 4 (19)
Late retrograde aortic dissection 0 (0)
Need for open conversion 0 (0)
Late endoleaks (after 30 days)
Type Ia 0
Type Ib 0
Type II 2 (10)
Type III 0
Endoleak requiring reintervention 2 (10) 1 LSCA
embolization and 1
balloon aortic stent
remodeling
LSCA, Left subclavian artery.
Data are presented as number (%) unless otherwise indicated.
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(6-120 weeks). The median hospital stay was 4 days
(2-14 days). There were no in-hospital deaths, no con-
versions to open surgical repair, no early or late supra-aortic
vessel occlusions, and no retrograde dissections. One pa-
tient (patient 5) suffered a stroke, as described before. She
died 6 months later at home. There were no cases of
postoperative paraplegia, and no patient had documented
cardiac complications or aortic rupture during the follow-
up period. There were no cases of type I endoleak or sig-
niﬁcant sac enlargement on follow-up imaging. None of
the patients in this cohort required reintervention to date.
DISCUSSION
Since Kruger et al ﬁrst described the use of custom-
made scalloped endografts in cases of inadequate proximal
landing zone,13 the technique has become increasingly
used in both the thoracic and abdominal aorta to preserve
ﬂow into branch vessels. The published literature on the
use of proximal scallops remains sparse, however.
Our group has previously published the ﬁrst case series
of four patients describing early outcomes after proximal
scalloped TEVAR, demonstrating the feasibility and safety
of this technique.7
Proximal seal was achieved in all cases in our series with
no type I endoleaks. These results suggest that scalloped
TEVAR is a viable therapeutic option for thoracic aortic
aneurysms with a short proximal landing zone. ScallopedTEVAR allows the distal aortic arch to be considered a
robust landing zone when the scallop is for the LSCA.
More data are required, however, to establish whether
this applies to more proximal aortic arch.
The custom-made scallop may complement modular
branch stent grafts, providing an entirely endovascular so-
lution for aortic arch disease.14 Scalloped endografts may
be used when the aortic pathology involves the origin of
the LSCA, LCCA, or innominate artery. They are less inva-
sive and less technically challenging compared with
modular stent grafts, resulting in shorter procedure times
and potentially fewer complications. Scalloped endografts
provide an alternative therapeutic option when modular
stent grafts are not suitable, for instance, when there is a
short proximal landing zone (<2 cm) or in cases of a
tortuous aneurysm neck.
The scallop is a continuation of the stent without the
polyester vascular graft. This therefore exposes a small
part of the aortic arch to what is essentially a bare-metal
stent. To date, we have not encountered any cases of retro-
grade aortic dissection or aortic wall perforation. Long-
term follow-up is needed, however, to assess durability of
this design.
Similar to the Relay thoracic stent grafts, scalloped
endografts have a curved nitinol wire along their length
providing longitudinal support, ﬂexibility, and torque
response. This design has proved durable during short-
term and midterm follow-up.4,15-17 To date, we have had
no cases of support wire failure with the scalloped
endografts.
Lu et al published a study of 22 patients with type B
aortic dissection, two of whom had TEVAR with LSCA
scallops and two with LSCA fenestrations; the remainder
had a hybrid repair with conventional stent grafts and
arch revascularization. The study’s small numbers and the
younger population with a lower burden of comorbidities
as well as the different aortic diseases make a direct compar-
ison with our data difﬁcult.18
We used scalloped endografts not only in patients with
distal aortic arch disease but also in patients with more
proximal disease after revascularization procedures with
scallops to the LSCA, LCCA, and innominate arteries.
The alternative for these patients would have been aortic
arch replacement surgery on cardiopulmonary bypass,
with signiﬁcant associated mortality and morbidity, partic-
ularly in a population of elderly patients.19-22 Recently, our
unit and others have demonstrated outcomes from hybrid
thoracic aortic aneurysm repair comparable to those of
conventional open techniques.23
One of the main advantages of scalloped TEVAR is
preservation of LSCA ﬂow without the need for extra-
anatomic bypass. Routine LSCA coverage during TEVAR
remains the subject of much debate. Although outcomes
after routine LSCA coverage in the absence of a dominant
left vertebral artery are deemed acceptable, there are re-
ports of arm claudication, ischemia, and stroke. Therefore,
many authors advocate preservation of LSCA ﬂow when-
ever possible.24 The 30-day mortality after TEVAR with
JOURNAL OF VASCULAR SURGERY
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2% to 6%.25,26 Reports on disability and quality of life vary
from no disability to development of severe arm claudica-
tion in a third of patients. Patients with a left vertebral ar-
tery diameter of <3 mm are more likely to develop
symptoms.27-29
Scalloped TEVAR provides an alternative to LSCA
coverage, with lower complication rates obviating the
need for open revascularization in some cases. Larger
studies are needed, however, to conﬁrm these ﬁndings as
well as to establish long-term outcomes and durability of
scalloped stent grafts.
Our series describes outcomes with use of scalloped
stent grafts in a heterogeneous group of patients with
different aortic aneurysm morphologies and etiologies to
illustrate the different potential uses of the device. The
complication rates, however, reﬂect the different groups’
surgical risks. Patients undergoing TEVAR for a thoracic
aortic aneurysm have a very different risk proﬁle from
that of elderly patients with extensive thoracoabdominal
aortic disease with multiple comorbidities requiring
TEVAR and hybrid repair. Unsurprisingly, the former
group has excellent outcomes after scalloped TEVAR
alone.
Patients in the second half of our series had fewer com-
plications and shorter hospital stay compared with patients
in the ﬁrst half, regardless of the type of surgery they un-
derwent. Although some of the differences may be due
to the shorter follow-up period for the patients in the sec-
ond half, they are also likely to reﬂect an initial learning
curve. Furthermore, as our center’s experience with endo-
vascular techniques improves, our selection of patients is
consonantly being reﬁned. Patients with atheromatous
aortic arch have a high risk of embolic infarcts,9 making
this a relative contraindication to TEVAR, perhaps even
more so with scalloped grafts as more manipulation is
needed for accurate deployment. For some of our patients,
this was the only therapeutic option, with the risk of aortic
rupture thought to outweigh that of potential
complications.
We are in the process of assessing whether the use of
robotic guidewire and catheter placement and manipula-
tion will reduce the incidence of embolic phenomena in
high-risk patients as this may result in more accurate, less
traumatic wire and catheter positioning.30,31
CONCLUSIONS
Our early and midterm outcomes suggest that scal-
loped TEVAR may provide an acceptable alternative treat-
ment option for thoracic aortic aneurysms involving the
great vessels, particularly when it is used without extra-
anatomic bypass. Further studies, in particular long-term
outcome data, are needed to establish the advantages and
durability of custom-made scalloped thoracic endografts.
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